FTC Wants More Info On AbbVie's $550M Device Deal
The Federal Trade Commission has requested more information about AbbVie's planned $550 million purchase of Soliton, a Houston-based company that makes medical devices for the treatment of cellulite and to aid...To view the full article, register now.
Already a subscriber? Click here to view full article